Abstract
Hypoxia plays a fundamental role in the pathophysiology of common causes of mortality, including ischemic heart disease, stroke, cancer, chronic lung disease, and congestive heart failure. In these disease states, hypoxia induces changes in gene expression in target organs that either fail to result in adequate adaptation or directly contribute to disease pathogenesis. Hypoxia-induciblc factor I (HIF-1) is a transcriptional activator that is expressed in response to cellular hypoxia and mediates multiple cellular and systemic homeostatic responses to hypoxia. Recent studies have provided evidence that important pathophysiological responses to hypoxia in pulmonary hypertension, myocardial ischemia, and cancer are mediated by HIF-1. Pharmacologic and gene therapy strategies designed to modulate HIF - 1 activity may represent a novel and effective therapeutic approach to these common disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benjamin, L.E., Memo, I., and Keshet, E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:8761–8766, 1998.
Bergwerff, M., Verberne, ME., DeRuiter, M.C., Poelmann, R.E., and Gittenberger-de Groot, A.C. Neural crest cell contribution to the developing circulatory system: implications for vascular morphology? Circ. Res. 82:221–231,1998.
Brizel, D.M., Scully, S.P., Harrelson, J.M., Layfield, L.J., Bean, J.M., Prosnitz, L.R., and Dewhirst, M.W. Tumor oxygenation predicts the likelihood of distant metastases in human soft tissue sarcomas. Cancer Res. 56:941–943, 1996.
Feldser, D., Agani, F., Lyer, N.V., Pak, B., Ferreira, G., and Semenza, G.L. Reciprocal positive regulation of hypoxia-inducible factor 1a and insulin-like growth factor 2. Cancer Res. 59:in press, 1999.
Forsythe, J.A., Jiang, B.-H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D., and Semenza, G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604–4613, 1996.
Fujimoto, K. Pericyte-endothelial gap junctions in developing rat cerebral capillaries: a fine structural study. Anat. Rec. 242:562–565, 1995.
Fukuiishi, Y., and Morriss-Kay, G.M. Migration of cranial neural crest cells to the pharyngeal arches and heart in rat embryos. Cell Tissue Res. 268:1–8, 1992.
Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364, 1996.
Helmlinger, G., Yuan, P., Dellian, M., and Jain, R.K. Interstitiial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a alack of correlation. Nat. Med. 3:177–182,1997.
Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509–4515,1996.
Huang, L.E., Gu, J., Schau, M., and Bunn, H.F. Regulation of hypoxia-inducible factor la is mediated by an O2-dcpendent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95:7987–7992, 1998.
Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., Gassmann, M., Gearhart, J.D., Lawler, A.M., Yu, A.Y., and Semenza, G.L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1a. Genes Dev. 12:149–162, 1998.
Jiang, B.-H., Agani, P., Passaniti, A., and Semenza, G.L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57:5328–5335, 1997.
Jiang, B.-H., Semenza, G.L., Bauer, C., and Marti, H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271:C1172–C1180, 1996.
Kallio, P.J., Wilson, W.J., O’Brien, S., Makino, Y., and Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1a by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:6519–6525, 1999.
Kotch, L.E., Iyer, N.V., Laughner, E., and Semenza, G.L. Defective vascularization of HIF-1 a-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 209:254–267, 1999.
Lewis, B.S., Flugelman, M.Y., Weisz, A., Keren-Tal, I., and Schaper, W. Angiogenesis by gene therapy: a new horizon for myocardial revascularization? Cardiovasc. Res. 35:490–497, 1997.
Martin, C., Yu, A.Y., Jiang, B.-H., Davis, L., Kimberly, D., Hohimer, A.R., and Semenza, G.L. Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178:527–534, 1998.
Maxwell, P.H., Dachs, G.U., Gleadle, J.M., Nicholls, L.G., Harris A.L., Stratford, I.J., Hankinson, O., Pugh, C.W., and Ratcliffe, P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94:8104–8109, 1997.
Maxwell, P.H., Wiesener, M.S., Chang, G.-W., Clifford, S.C., Vaux, B.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275, 1999.
Ryan, H.E., Lo, J., and Johnson, R.S. HIF-1a is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015,1998.
Salceda, S., and Caro, J. Hypoxia-inducible factor la (HIF-1a) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: its stabilization by hypoxia depends upon redox-induced changes. J. Biol. Chem. 272: 22642–22647, 1997.
Semenza, G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8:588–594, 1998.
Semenza, G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Genet. Dev. 15:551–578, 1999.
Semenza, G.L., and Wang, G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447–5454,1992.
Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49:6449–6465, 1989.
Wang, G.L., Jiang, B.-H., Rue, E.A., and Semenza, G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92:5510–5514, 1995.
Wang, G.L., and Semenza, G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230–1237, 1995.
Yu, A.Y., Frid, M.G., Shimoda, L.A., Wiener, C.M, Stenmark, K., and Semenza, G.L. Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor 1 in the lung. Am. J. Physiol. 275:L818–L826, 1998.
Yu, A.Y., Shimoda, L.A., Iyer, N.V., Huso, D.L., Sun, X., McWilliams, R., Beaty, T., Sham, J.S.K., Wiener, C.M., Sylvester, J.T., and Semenza, G.L. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1a. J. Clin. Invest. 103:691–696, 1999.
Zetter, B.R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49:407–424, 1998.
Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L., and Simons, J.W. Overexpression of HIF-1a in common human cancers and their metastases. Submitted for publication, 1999.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Semenza, G.L. et al. (2002). Hypoxia, HIF-1, and the Pathophysiologi of Common Human Diseases. In: Lahiri, S., Prabhakar, N.R., Forster, R.E. (eds) Oxygen Sensing. Advances in Experimental Medicine and Biology, vol 475. Springer, Boston, MA. https://doi.org/10.1007/0-306-46825-5_12
Download citation
DOI: https://doi.org/10.1007/0-306-46825-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46367-9
Online ISBN: 978-0-306-46825-4
eBook Packages: Springer Book Archive